Welcome
NanGenex, member of the DRGT Group, is a Druggability Enabling High Throughput NanoActiveâ„¢ Technology Platform Company. The company utilizes its integrated platform to provide breakthrough solutions to pharmaceutical, agrochemical and cosmetic companies in order to develop new generations of NanoActive products with significant performance benefits over conventional approaches.
The technology platform enables NanGenex to generate proprietary NanoActiveâ„¢ materials by altering their physico-chemical properties to substantially improve their solubility, dissolution rate and bioavailability.
News
Latest Press ReleaseSAN FRANCISCO, CA, January 12, 2012 Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, announced today that it has completed an initial round of financing totaling $4,000,000. Read more |
Upcoming eventMarch 1-2, 2012, Krems, Austria |